Very little is known about the occurrence and various types of extended-spectrum b-lactamase (ESBL), AmpC and carbapenemase in Iran. The aims of this study were to determine the prevalence of ESBLs, AmpCs and carbapenemase genes among Enterobacteriaceae in Azerbaijan and to characterize the genetic composition of the detected genes. A total of 307 Enterobacteriaceae isolates, recovered from five medical centres, were screened for ESBL, AmpC and carbapenemase activities by the disc diffusion method and phenotypic confirmatory tests. The 162 selected strains (third-generation cephalosporins, cefoxitin-or carbapenemresistant strains with positive or negative phenotypic confirmatory tests) were selected for multiplex PCR screening for b-lactamase genes, and detected genes were confirmed by sequencing. Of 162 isolates, 156 harboured 1 to 6 b-lactamase genes of 41 types. The most prevalent genes were bla TEM-1 (29.9 %), followed by bla CTX-M-15 (25.7 %). Plasmid-mediated AmpC was detected in 66 strains (21.5 %) alone or in combination with other genes. Carbapenemase-encoding genes were detected in 18 strains (5.8 %) of 27 carbapenem-nonsusceptible isolates including 11, 7, 3 and 1 cases of bla OXA-48 , bla NDM-1 , bla KPC-2 and bla KPC-3 genes, respectively. Interestingly, 148 (94.8 %) of 156 strains with any b-lactamase gene were found to have a multidrug-resistant pattern. The rate of resistance to b-lactams and multidrugresistant Enterobacteriaceae is high in Azerbaijan. All positive strains for carbapenemase genes were resistant to all b-lactams. The present study reveals the high occurrence of CTX-M-type ESBLs followed by TEM and SHV variants among Enterobacteriaceae isolates. East Azerbaijan seems to be an alarming focus for OXA-48, NDM-1 and KPC dissemination.
INTRODUCTION
b-lactamase production has emerged as the most important mechanism for b-lactam resistance among the Enterobacteriaceae family. Several types of acquired b-lactamases belonging to Ambler classes, including extended-spectrum b-lactamases (ESBLs; Ambler class A) acquired Ambler class C cephalosporinases, i.e. plasmid-mediated AmpCs (pAmpCs; Ambler class C) and carbapenemases (Ambler classes B and D), conferring resistance to different b-lactam agents have been described. The ESBLs are b-lactamases capable of conferring bacterial resistance to penicillins first-, second-and third-generation cephalosporins and aztreonam but not cephamycins or carbapenems (Paterson & Bonomo, 2005) . The CTX-M, TEM and SHV variants are the most prevalent ESBLs in nosocomial and community settings (Bradford et al., 2004; Paterson & Bonomo, 2005; Cantón & Coque, 2006) . However, a variety of other b-lactamases with ESBL activity such as VEB, PER, BEL, GES/ IBC and OXA b-lactamases have been defined worldwide (Paterson & Bonomo, 2005) .
pAmpCs are constitutively expressed enzymes that have emerged through the mobilization of inducible chromosomal AmpC genes from resistant organisms such as Pseudomonas and Acinetobacter to the members of the Enterobacteriaceae family, especially Escherichia coli and Klebsiella pneumoniae, without any changes in substrate profiles (Jacoby, 2009 ).
Unfortunately, the emergence of carbapenemase-producing Enterobacteriaceae, during the past 10 years, has seriously compromised the therapeutic options for drug-resistant infections. Carbapenemases, particularly NDM, KPC and OXA-48, have been increasingly described among members of this family. These enzymes are associated with multidrug resistance to the vast majority of b-lactam drugs, so they are described as 'versatile b-lactamases' (Queenan & Bush, 2007; Nordmann et al., 2011a, b) .
Limited therapeutic options for treatment of infections caused by b-lactamase-producing Enterobacteriaceae lead to higher mortality rates and medical costs compared to non-blactamase-producing strains (Marchaim et al., 2010) . Therefore, resistance surveillance programmes and understanding the resistance mechanisms are crucial for appropriate antimicrobial chemotherapy. Until now, there has been no significant information on the prevalence of ESBL, AmpC and carbapenemase genes among members of the family Enterobacteriaceae in Azerbaijan, Iran. Studies in this area are rare and mostly focused on a few genes in certain isolates of Enterobacteriaceae and certain health centres. In a recent study in Tehran, Japoni-nejad et al. (2014) reported that 19 and 12 % of K. pneumoniae strains are positive for pAmpCs and carbapenemase genes, respectively. In this report, bla CMY-2 , bla MOX and bla VIM were the most prevalent genes among pAmpCs and carbapenemases, respectively. In an other report from the Study for Monitoring Antimicrobial Resistance Trends, which that was performed in the AsiaPacific region, bla CTX-M-15 was the most common ESBL gene, followed by bla SHV and bla TEM , among intra-abdominal isolates of Enterobacteriaceae. Moreover, bla CMY-2 , bla DHA and bla ACT/MIR were the most common pAmpC b-lactamase genes, and bla NDM was the most common carbapenemase gene among all isolated carbapenemase-producing strains from India (Sheng et al., 2013) . In this study, for a comprehensive view on the emergence and epidemiology of ESBLs, AmpCs and carbapenemase genes, 162 cephalosporin/carbapenem-resistant Enterobacteriaceae strains, collected from five major medical centres of Azerbaijan, were analysed.
METHODS
Clinical isolates. Three hundred and seven non-duplicated Enterobacteriaceae isolates were consecutively collected from five medical centres in West (127 patients) and East Azerbaijan (180 patients), Iran, during January to July 2014. All patients with at least 7 days of hospitalization and clinically confirmed nosocomial infections from various clinical settings were included. Only one isolate per patient was included in the study, and patients who were admitted with clinical infections were excluded. The identification was performed using standard biochemical tests and confirmed by the API-20enteric identification system (bio-M erieux). Institutional review board approval was obtained from the ethical review board of the Tabriz University of Medical Sciences.
Antimicrobial susceptibility testing. The susceptibility of all isolates was tested against third-generation cephalosporins (ceftazidime, cefotaxime and ceftriaxone), carbapenems (imipenem, meropenem and ertapenem) and cefoxitin using the disc diffusion method as initial screening method for b-lactamase genes, according to the CLSI (2012) recommendations. The susceptibility of positive isolates for any b-lactamase gene was also determined against cefepime, ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam, ciprofloxacin, gentamicin, amikacin and trimethoprim-sulfamethoxazole. All discs were purchased from Rosco Diagnostica. Categorical interpretations recommended in the CLSI (2015) document M100-S25 were considered for selected antimicrobial agents. Escherichia coli ATCC 25922 and K. pneumoniae ATCC 700603 were used as quality control strains. The isolates were selected based on the CLSI screening criteria for ESBL (ceftazidime zone 22 mm, cefotaxime zone 27 mm and ceftriaxone zone 25 mm), carbapenemase (ertapenem 19-21 mm and meropenem 16-21 mm) and AmpC (cefoxitin inhibition zone <20 mm designated as possible AmpC hyper-producers) according to CLSI (2012) . The phenotypic confirmatory tests were performed using all three, ESBL/AmpC, KPC/ MBL and OXA-48, confirmation kits (Rosco Diagnostica). The results of the confirmatory tests were interpreted according to the CLSI guidelines and manufacturer's recommendations.
Molecular detection of b-lactamases. All 162 selected strains (based on initial screening and phenotypic confirmatory tests) and 27 carbapenem-non-susceptible strains were further evaluated for presence of ESBL/pAmpC and carbapenemase genes, respectively, by PCR and sequencing of related encoding genes including bla TEM , bla SHV , bla CTX-M , bla GES , bla VEB and bla PER ; bla CMY , bla ACC , bla ACT , bla FOX , bla DHA , bla LAT , bla MOX and bla MIR ; and bla IMP , bla VIM , bla GIM , bla SIM , bla SPM , bla KPC , bla NDM , bla SME , bla IMI , bla NMC-A , bla GES and bla . We used the following set of multiplex PCR assays for detection of blactamase genes: multiplex PCR I, II, IV and VI previously described by Dallenne et al. (2010) for the detection of bla TEM , bla SHV , bla CTX-M , bla-GES , bla VEB , bla PER , bla IMP , bla VIM and bla KPC and groups A, B, C1, C2 and D1 described by Voets et al. (2011) for the detection of bla SME-1-3 , bla IMI-1-3 , bla NMC-A , bla GIM-1 , bla SIM-1 , bla NDM-1 , bla SPM-1 , bla [8] [9] [10] [11] 19 , bla [5] [6] [7] , bla 7 , bla ACC-1-4 , bla CMY-2 , bla 4 , bla , bla 8 , bla FOX-1-8 and bla . Total DNA was prepared from one heated colony (95 C for 10 min) from overnight colonies grown on agar in 20 µl of tissue buffer (0.25 % SDS and 0.05 M NaOH) followed by a centrifugation step at 13 000 g for 1 min. DNA concentrations of supernatants were adjusted to 50 ng µl À1 , and one µl was subjected to each multiplex PCR in a 25 µl reaction mixture containing 1Â PCR buffer (10 mM Tris/HCl, pH 8.3, 50 mM KCl and 1.5-2 mM MgCl 2 ), 50 mM of each deoxynucleotide triphosphate, 1 U of Taq polymerase (Sigma-Aldrich) and a variable concentration of specific group primers. Amplification was performed using conditions previously described by Dallenne et al. (2010) with some modifications. The optimal annealing temperatures of 56 C for amplification of bla VIM , bla IMP and bla KPC and 56.5 C for bla GES and bla OXA-48 genes were used for the respective multiplex PCR assays. Amplification products were visualized after running them at 100 V for 1 h on a 1 % agarose gel containing ethidium bromide. A 100 bp DNA ladder (CinnaGen) was used as a size marker. In this study, strains for quality control of each gene were provided from the microbiology department of the Tabriz Institute for Pharmaceutical Research.
To identify the b-lactamase genes, sequencing of the resulting PCR amplicons was done using the same primers as for PCR. The amplified PCR products were purified using the QIAquick PCR Purification kit (Qiagen Company), and bidirectional sequencing was performed using an ABI 3730XL DNA analyser. Each sequence was then searched against already known b-lactamase gene sequences using the nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the Lahey Clinic database (http://www.lahey.org/studies/).
Data analysis. The descriptive statistics, including the frequencies, case summaries and cross tabulation of clinical, microbiological and epidemiological characteristics, was done using the software SPSS, version 21.
RESULTS

Initial screening for b-lactamase genes
Three hundred and seven non-duplicated Enterobacteriaceae isolates (180 and 127 strains from East and West Azerbaijan, respectively) were recovered from various samples and clinical settings (Table 1) . Based on the initial screening (Table 2) and phenotypic confirmatory tests (data not shown), 162 (52.7 %) of 307 Enterobacteriaceae were suspected for presence of blactamase genes among which 111, 33 and 27 strains met selection criteria for ESBL, AmpC hyper-producer and carbapenemase activities, respectively, and were selected for further molecular evaluation. In the case of ESBL, six strains of 111 initially suspected ESBL isolates were positive based on the disc diffusion method, but none of them showed ESBL activity or genes in the phenotypic confirmatory test and PCR, respectively. The overall rates of resistance to cefoxitin, cefepime, ceftazidime, cefotaxime, ceftriaxone, imipenem, meropenem and ertapenem were 40.1, 50, 75.9, 90.1, 91.3, 9.9, 9.3 and 13.8 %, respectively, among all 307 strains screened for b-lactamase activities. The results of initial screening of all Enterobacteriaceae isolates for b-lactamase genes are presented in Table 2 .
Multiplex PCR screening and sequencing for b-lactamase genes Of 162 resistant strains, 156 carried ESBLs, carbapenemases and/or acquired AmpC encoding genes. The overall prevalence of detected b-lactamase genes among clinical isolates of Enterobacteriaceae is presented in Fig. 1 . Forty-one types of blactamases and 83 different combinations (two to six b-lactamases) were detected ( Table 3 ). The remaining six strains displayed no encoding genes in multiplex PCR screening, comprising three Enterobacter cloacae, two Morganella morganii and one Serratia marcescens. All of these strains had a cefoxitin inhibition zone <20 mm and a positive phenotypic confirmatory test for AmpC hyper-producer activity indicating hyper-expression of intrinsic (chromosomal) cephalosporinase.
bla was the most prevalent CTX-M b-lactamase gene detected by PCR and sequencing (25.7 %, 79 strains of 307). This gene was detected in 32 combinations with one to five additional b-lactamase genes, and only one isolate had bla CTX-M-15 alone. of 79 bla CTX-M-15 -positive strains, 51 and 28 were from East (28.3 %) and West (22 %) Azerbaijan, respectively. This gene was detected in the internal (41 isolates) and surgery (18 isolates) wards, followed by the intensive care unit (ICU) (8 strains), paediatric ward and burn ward (6 strains each). Positive strains for both bla CTX-M-15 and carbapenemase-encoding gene were observed among six (bla ) and four (bla NDM-1 ) isolates. Forty-one isolates carried other bla CTX-M variants (Table 3 ). The bla , bla , bla and bla were detected in 16 K. pneumoniae strains, and bla SHV-2a and bla were detected in 1 Escherichia coli strain.
Other Ambler class A genes were included such as bla TEM , bla VEB-1 , bla GES-like , bla PER-1 and bla . Broad-spectrum b-lactamases bla , bla SHV-1 , bla VEB-1 and bla were the most frequent among this class and were noted alone or in combination with other genes in 60, 13, 12 and 10 strains, respectively.
Additionally, acquired AmpC cephalosporinases were detected in 66 strains (21.5 %) alone or in combination with other genes. The most prevalent genes among this class were bla CMY-2 , followed by bla DHA-1 , bla ACT-1 , bla FOX-1 , bla MIR-1 , bla LAT-1 , bla MOX-1 , bla , bla CMY-6 , bla CMY-11 and bla . Of 66 pAmpC-positive strains, 49 and 17 were from East (27.2 %, overall prevalence among 180 isolates) and West (13.4 %, among 127 strains) Azerbaijan, respectively. These strains were isolated from the internal (40 cases) and surgery (13) wards, followed by the ICU (6), burn ward (6) and paediatric ward (1).
All carbapenem-non-susceptible isolates (27 strains) were analysed for the presence of carbapenemase-encoding genes. We detected 18 positive strains for carbapenemase genes including 11, 7, 3 and 1 cases of bla , bla NDM-1 , bla KPC-2 and bla KPC-3 genes, respectively. These isolates were recovered in two hospitals (Sina and Imam Reza) located in Tabriz (East Azerbaijan). Three and one strains of bla KPC -positive isolates (all of which were from Sina Hospital) were also positive for bla and bla NDM-1 , respectively. Five positive strains for bla NDM-1 were from Sina Hospital, and only two strains were detected in the Imam Reza Hospital. Of 11 bla OXA-48 -positive strains, nine were from Sina Hospital, and two strains were from Imam Reza Hospital. The remaining five negative strains for any carbapenemase genes were intermediate against ertapenem and susceptible to meropenem and imipenem. No carbapenemase-encoding genes were detected in the cities of Urmia and Khoy (West Azerbaijan). Other types of carbapenemase genes were not detected among study strains. The amplification products of the expected sizes are illustrated in Fig. 2 . There are no mismatches between PCR and sequencing methods, and all PCR products of suspected genes were confirmed by sequencing.
Susceptibility pattern of positive strains for b-lactamase genes
The susceptibility pattern of all positive strains for two to six different b-lactamase gene combinations is presented in Table 3 . The susceptibility rates to the non-b-lactam antibiotics amikacin, gentamicin, ciprofloxacin and cotrimoxazole were 91, 50.6, 30.7 and 28.2 %, respectively, among all 156 
DISCUSSION
The limited comprehensiveness of previous studies regarding b-lactamase, made us evaluate the prevalence and genetic composition of ESBLs, AmpCs and carbapenemase genes among members of the Enterobacteriaceae family in Azerbaijan, Iran. Based on our findings suggesting the relatively unknown diversities of b-lactamases in Azerbaijan similar to other parts of Iran, constant monitoring and surveillance of b-lactamase-related resistance mechanisms still seem to be critical. As in other regions of the world, CTX-M b-lactamases including groups 1 and 9 were very prevalent, and bla CTX-M-15 was one of the most common ESBL types (Cantón & Coque, 2006) . Positive strains for bla CTX-M-15 were detected in five medical centres covering the majority of admitted patients from different states of East and West Azerbaijan of Iran and the neighbouring Republic ESBL, AmpC and carbapenemase in Iran of Azerbaijan. Most reports of CTX-M genes among Enterobacteriaceae in Iran are based on the genotypic detection of the CTX-M family without any nucleotide sequence analysis for specific detection of CTX-M types (Nematzadeh et al., 2011; Moosavian & Deiham, 2012; Safari et al., 2013; Rezai et al., 2015) . In this respect, our value for bla CTX-M-15 -positive Enterobacteriaceae strains (50.6 %, among resistant strains) was in accordance with the previous report by Feizabadi et al. (2010) . In the current study, the prevalence of bla CTX-M-15 among ESBL isolates was 65.1 %. Comparing this value with reported data from the SENTRY Program study in 2007 (16.0 %) and 2010 (33.8 %) clearly indicates the high proportion of strains harbouring the bla CTX-M-15 gene, which represents very stable circulation of the mobile genetic elements carrying this particular ESBL in Iran (Cantón & Coque, 2006; Castanheira et al., 2008) . In addition to bla , other bla CTX-M , bla TEM and bla SHV variants were prevalent, similar to the observations of Castanheira et al. (2014) and Sheng et al. (2013) . The most common gene compositions for bla positive strains were bla CTX-M-15 /bla TEM-1 (46 isolates), followed by bla CTX-M-15 / bla TEM-116 (29 isolates), bla CTX-M-15 /pAmpCs (29 isolates; the most common combinations include 15 bla CMY-2 and 9 bla DHA-1 ) and bla CTX-M-15 /bla SHV (18 isolates; the most common combinations include 7 bla SHV-1 , 4 bla SHV-12 and 4 bla ). These findings were in complete agreement with observations made by Castanheira et al. (2014) for all bla CTX-M-15 /bla TEMand bla CTX-M-15 /bla SHV -type combinations. The remaining 34 strains, harbouring the bla CTX-M-15 gene, also carried encoding genes for other b-lactamases including carbapenemases (bla NDM-1 , bla and bla GES-like ), CTX-M group 9 and bla VEB-1 . In addition, we found that the most commonly detected pAmpCs were bla CMY-2 in E.coli, bla DHA-1 in K. pneumoniae and bla ACT/MIR in Enterobacter cloacae isolates, which is in agreement with the study of Sheng et al. (2013) .
In the present work, bla , bla NDM-1 and bla KPC were the only detected carbapenemase genes in 11, 7 and 4 K. pneumoniae strains, respectively. Despite similar data with regard to ESBL and AmpC occurrence, different patterns were observed among carbapenemase-positive strains in contrast to the observations of Castanheira et al. (2014) and Sheng et al. (2013) . Our data clearly indicated that the proportion of strains containing bla OXA-48 genes was relatively higher than those for bla NDM-1 and bla KPC genes. Based on data from the present study and data from the Study for Monitoring Antimicrobial Resistance Trends reporting the rapid emergence of bla NDM -producing isolates in India and also recent anecdotal reports of bla NDM genes from Iran, it seems that a similar pattern may exist for distribution of bla NDM genes in Azerbaijan (Shahcheraghi et al., 2013; Sheng et al., 2013) .
Single isolates carrying multiple genes were previously described and were recognized as a major threat for antibacterial chemotherapy (Queenan & Bush, 2007) . Similar to the observations of Castanheira et al. (2013) , the most important combinations were observed among K. pneumoniae strains frequently carrying multiple and broadspectrum b-lactamases indicating the fact that these organisms were able to accumulate several multidrug-or pan-resistant determinants (Queenan & Bush, 2007; Castanheira et al., 2013) . In the present study, strains carrying two to four b-lactamase genes were commonly detected. However, we detected nine and three K. pneumoniae strains carrying five and six genes, respectively, including bla KPC , bla NDM and bla and several types of ESBLs and pAmpCs. In the aspect of the occurrence, these findings were similar to the observations of Bradford et al. (2004) and Castanheira et al. (2013) , but the frequency of K. pneumoniae strains carrying up to five and six genes was higher in our institutions.
According to the antimicrobial susceptibility results, imipenem, meropenem and ertapenem were the most effective antibiotics against all positive strains for any b-lactamase gene (except for strains carrying carbapenemase genes, all of which were resistant to examined antimicrobials in this study), followed by amikacin, piperacillin/tazobactam, amoxicillin/clavulanic acid and gentamicin. The high rate of multidrug-resistant pattern among Enterobacteriaceae strains carrying any b-lactamase gene in this study may be attributed to high selection pressure because of self-medication, overuse and empirical use of third-generation cephalosporins and carbapenems without careful monitoring of resident multidrug-resistant isolates in hospital settings, particularly in the ICU, surgery ward and burn ward. For these reasons, further surveillance programmes in this area are needed.
Our study has some limitations. First, the numbers of examined Enterobacteriaceae isolates were not equal from each province. Second, we used the disc diffusion method rather than MIC for screening and assessing the individual resistance rates. Third, a phenotypic confirmatory method performed in this study using Rosco confirmatory kits was not approved by CLSI, but we used the same b-lactamase inhibitors recommended by CLSI. Finally, molecular epidemiology, such as PFGE, was not performed in this work. For this reason, epidemiological relatedness of the multidrug-resistant strains, particularly isolates with carbapenemase genes and dissemination patterns of resistant lineages, remain, to be evaluated.
In conclusion, the rate of resistance to b-lactams and multidrug-resistant Enterobacteriaceae is high in Azerbaijan. The present study reveals the high occurrence of bla ESBLs followed by bla 
